Skip to main content
Elsevier
View Cart

Books in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

BooksJournals

    • The Organic Chemistry of Drug Design and Drug Action

      • 4th Edition
      • March 12, 2026
      • Richard B. Silverman + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 5 8 6 2 9
      • eBook
        9 7 8 0 4 4 3 1 5 8 6 3 6
      The Organic Chemistry of Drug Design and Drug Action, Fourth Edition presents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action. The book's coverage allows readers to extrapolate core principles and mechanisms to many related classes of drug molecules. It reflects the significant changes in the process of drug design over the last decade and preserves the successful approach of the previous editions while also including significant changes in format and coverage.It is designed for undergraduate and graduate students in chemistry who are studying medicinal chemistry or pharmaceutical chemistry. Users, including research chemists and biochemists working in pharmaceutical and biotechnology industries will find this update to be useful in their daily work.

    • Basic Principles of Drug Discovery and Development

      • 3rd Edition
      • March 6, 2026
      • Benjamin E. Blass
      • English
      • Paperback
        9 7 8 0 4 4 3 1 5 7 4 7 9
      • eBook
        9 7 8 0 4 4 3 1 5 7 4 6 2
      Basic Principles of Drug Discovery and Development, Third Edition presents a unique overview of the drug discovery and development program not available elsewhere. Each chapter provides sufficient technical details on the topics covered so that non-experts will have the tools and information necessary to interact and exchange information with colleagues across the entire spectrum of the drug discovery and development process. The drug discovery and development process involves individuals and teams with a wide array of expertise ranging from basic sciences (medicinal chemistry, biology) to applied science (pharmacology, pharmacokinetics, clinical sciences) to business driven fields (regulatory affairs, intellectual property experts, marketing specialists).The success or failure of a program focused on bringing a new medication to market often depends on clear communication between individuals and teams with vastly different expertise. As a result, it is critical that experts in one aspect of drug discovery and development (e.g., medicinal chemists) have a working understanding of the wide range of disciplines that take part in the overall process.

    • Innovative Nanocarriers for Stimulated Drug Delivery

      • 1st Edition
      • March 1, 2026
      • Prashant Kesharwani
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 6 4 1 6
      • eBook
        9 7 8 0 4 4 3 3 3 6 4 2 3
      Innovative Nanocarriers for Stimulated Drug Delivery: A Comprehensive Guide to Stimuli-responsive Nanoparticles offers a thorough exploration of the latest developments in nanocarrier technologies that react to various external and internal stimuli. Designed for pharmaceutical professionals and graduate students, this guide provides essential knowledge, spanning from foundational principles to clinical applications. Covering regulatory considerations and experimental techniques, the book equips readers with a deep understanding of the formation, characterization, and use of stimuli-responsive nanoparticles in drug delivery, therapy, and theranostics, making it an invaluable resource for advancing research and practical expertise in this dynamic field.The book is structured into six distinct parts, with each addressing a critical aspect of stimuli-responsive nanocarriers. It examines external stimuli such as ultrasound and magnetic fields, internal triggers like pH and enzymes, and dual or multimodal systems. Dedicated sections discuss therapeutic applications for cancer and noncancerous diseases, as well as regulatory challenges including toxicity, safety, and clinical translation. Authored by leading experts, the guide serves as a definitive reference for researchers, pharmaceutical scientists, and graduate students, ensuring comprehensive insights into both current achievements and future directions in nanomedicine.

    • AI Powered Drug delivery to Neuro and Cardiovascular Systems

      • 1st Edition
      • March 1, 2026
      • Chandra P. Sharma + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 4 4 1 2
      • eBook
        9 7 8 0 4 4 3 4 0 4 4 2 9
      AI-Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges is a definitive reference exploring the transformative influence of Artificial Intelligence (AI) in neuro and cardiovascular drug delivery. This book integrates cutting-edge research to explain how AI is poised to reshape clinical protocols, therapeutic strategies, and regulatory standards. By examining advancements in robotics and intelligent systems, it demonstrates how AI enhances precision, personalization, and efficiency in drug delivery for heart and neurological conditions, providing readers with a thorough understanding of these innovations and their potential to revolutionize healthcare practices.The book delves into AI-driven drug design and testing for cardiovascular diseases and explores the application of AI in cardiac drug delivery vehicles. It discusses bioengineered heart and vessel therapeutics, redox homeostasis, and targeted drug replenishment in cardiac matrix remodeling. Additionally, it addresses mitochondrial drug retention, AI-assisted gene therapy for neurodegenerative disorders, and the role of AI in optimizing heart health. The text highlights smart systems for managing cerebrovascular accidents and neuromodulation with pharmacotherapy. Finally, it covers translational challenges, future directions, and the significance of AI-driven prediction models and robotic delivery mechanisms.

    • Antibiotic Resistance and Nanotherapy

      • 1st Edition
      • February 1, 2026
      • Awanish Kumar + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 6 3 8 8 7
      • eBook
        9 7 8 0 4 4 3 3 6 3 8 9 4
      Antibiotic Resistance and Nanotherapy is a comprehensive guide that takes an interdisciplinary approach to address the pressing issue of antibiotic resistance and explores possibility of nanotherapy as a cutting-edge strategy to treat illnesses that are resistant to antibiotics, employing nanoparticles to target and kill bacteria selectively without damaging healthy cells. It details the underlying mechanisms of drug resistance in intracellular and extracellular pathogens and explores the latest advancements in nanotechnology, including the development of innovative nanomaterials and delivery systems that can be utilized to combat antibiotic-resistant infections. The book also tackles the ethical and practical challenges associated with implementing nanotherapy for bacterial resistance. Featuring contributions from experts in the field, Antibiotic Resistance and Nanotherapy is an essential resource for researchers, medical professionals, and policymakers seeking to understand and tackle the immediate threat posed by antibiotic resistance

    • How to Develop Robust Scale-up Strategies for Complex Injectable Dosage Forms

      • 1st Edition
      • February 1, 2026
      • Neelam Poonia + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 3 6 6 8
      • eBook
        9 7 8 0 4 4 3 4 0 3 6 7 5
      How to Develop Robust Scale-up Strategies for Complex Injectable Dosage Forms: From Bench to the Clinics is an essential guide providing a comprehensive roadmap for transitioning complex injectable formulations from the laboratory to clinical applications. Offering an in-depth exploration of various complex injectables, including liposomal dosage forms, nanoparticles, and microspheres, this book delves into the principles of dosage form design, excipient selection, stability studies, and optimization techniques. Readers will gain valuable insights into ensuring the stability, efficacy, and safety of injectables during the scale-up process, as well as strategies for maintaining product quality and consistency from lab-scale to commercial-scale production. The book thoroughly examines manufacturing technologies such as aseptic processing, sterile filtration, and lyophilization, and their applications in producing complex injectables. Detailed discussions on quality control measures, analytical techniques, and quality assurance practices are provided to ensure the consistent quality and purity of injectables throughout the manufacturing process. Readers will benefit from the expert knowledge and practical insights shared by industry professionals and leading researchers, including successful examples of marketed complex injectables. Highlighting best practices and regulatory requirements, this book offers a comprehensive overview of the guidelines for the development, manufacturing, and commercialization of complex injectables. Discussions on Good Manufacturing Practices (GMP) and regulatory submissions underscore the importance of compliance in achieving successful product development. Ideal for pharmaceutical scientists, formulation developers, and regulatory professionals, this book is a valuable resource for anyone involved in the scale-up and commercialization of complex injectable dosage forms.

    • Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management

      • 1st Edition
      • February 1, 2026
      • Harish Dureja + 5 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 3 9 4 6 9
      • eBook
        9 7 8 0 4 4 3 4 3 9 4 7 6
      Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management explores innovative drug delivery systems utilizing nanotechnology to revolutionize the treatment and management of COPD. By presenting the latest advancements in nanotechnologies—inc... polymeric nanoparticles, liposomes, and theranostic nanoparticles—this volume aims to enhance patient outcomes, alleviate symptoms, and improve lung function, thereby addressing the urgent need for more effective therapies. Structured to cater to a diverse audience, from beginners to advanced researchers, this comprehensive text begins with an overview of COPD, its epidemiology, and current limitations in treatment. The core chapters explore a wide range of nanotechnological applications for diagnosis and disease management, including cutting-edge topics such as nano-immunotherapy and green nanotechnology. Each chapter was developed by a multidisciplinary team of experts from academia and industry, ensuring a comprehensive approach that integrates insights from pharmaceutical sciences, respiratory health, and bioinformatics. Nanotechnology-based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management not only fills a critical gap in COPD literature but also serves as an invaluable resource for researchers, clinicians, and students alike. It promises to be a definitive guide on how innovative drug delivery systems can transform COPD care, paving the way for future advancements in respiratory health management.

    • Handbook of Pharmaceutical Wet Granulation

      • 2nd Edition
      • December 1, 2025
      • Ajit S. Narang + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 8 1 7 2
      • eBook
        9 7 8 0 4 4 3 2 9 8 1 8 9
      Handbook of Pharmaceutical Wet Granulation: Theory and Practice in a Quality by Design Paradigm, Second Edition offers a single and comprehensive reference dedicated to all aspects of pharmaceutical wet granulation, taking a holistic approach by combining introductory principles with practical solutions. Chapters are written by international experts across industry, academic and regulatory settings, and cover a wide spectrum of relevant and contemporary wet granulation topics, techniques and processes. This completely revised and updated edition features five new chapters covering new AI tools applied to scaling up granulation processes, model drive design, machine learning models for granule property prediction, design and scale up of fluid bed granulation, and process analytical methods. This book is the prefect reference for pharmaceutical manufacturing professionals. Academic researchers will benefit from the practical advice provided by the editors and chapter authors.

    • Functionalized Drug Delivery Systems

      • 1st Edition
      • December 1, 2025
      • Umesh Gupta + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 3 0 4 0
      • eBook
        9 7 8 0 4 4 3 3 3 3 0 5 7
      Functionalized Drug Delivery Systems delves into the potential of various functionalized drug delivery systems, such as polymeric micelles, dendrimers, metallic nanoparticles, and SMEDDS. It offers a comprehensive guide from basic concepts to advanced surface engineering techniques. The book covers liposomes, dendrimers, metal nanoparticles, polymeric micelles, niosomes, and ethosomes, concluding with a chapter on the regulatory framework. This invaluable resource is perfect for pharmaceutical researchers and graduate students keen on advancing their understanding and application of these innovative drug delivery methods. The book also provides consolidated literature reviews, making it a foundational text for new researchers.Its chapters are dedicated to specific techniques, offering detailed insights into each method. Readers will gain knowledge on improving drug absorption and targeted delivery, supported by practical examples and case studies. The final chapter on regulatory frameworks ensures compliance and best practices in developing functionalized drug delivery systems. This book is an essential read for anyone in the field of pharmaceutical research.

    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 47
      • December 1, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 3 4 4 8 5 5
      • eBook
        9 7 8 0 4 4 3 3 4 4 8 6 2
      Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 47, first published in 1977, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered include ADRs, ADEs and SEDs: A Bird’s Eye View, Lithium, Drugs of abuse, Side effects of drugs used in the treatment of Alzheimer's disease, Sedatives and hypnotics, Antipsychotic agents, Anti-epileptic Medications, Side effects of opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, Side effects of local anesthetics and therapeutic gases, and more.Other sections covered include Antihistamines (H1 receptor antagonists), Drugs that act on the respiratory tract, Positive inotropic drugs and drugs used in dysrhythmias, Beta adrenergic antagonists and antianginal drugs, Drugs acting on the cerebral and peripheral circulations, Antihypertensive drugs, and much much more.

Related subjects

Drug delivery

Drug design

Drug dispensing

Drug manufacturing and packaging

Drug metabolism disposition

Pharmaceutical analysis

Pharmaceutical biotechnology

Pharmaceutical quality control

Pharmaceutical science general

Pharmaceutical technology

Pharmacoeconomics

Pharmacoepidemiology

Pharmacotherapy

Pharmacy

Pharmacy management